Connor, Clark & Lunn Investment Management (CC&L)’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Sell
6,672
-220
-3% -$40.4K ﹤0.01% 1103
2026
Q1
$1.1M Sell
6,892
-1,656
-19% -$254K ﹤0.01% 1135
2025
Q4
$1.17M Sell
8,548
-433
-5% -$55.9K ﹤0.01% 1086
2025
Q3
$1.09M Buy
8,981
+4,172
+87% +$450K ﹤0.01% 1035
2025
Q2
$515K Buy
+4,809
New +$481K ﹤0.01% 1250
2024
Q4
Sell
-3,008
Closed -$378K 1561
2024
Q3
$378K Buy
+3,008
New +$378K ﹤0.01% 1172
2023
Q3
Sell
-8,237
Closed -$509K 1479
2023
Q2
$509K Buy
+8,237
New +$488K ﹤0.01% 979
2020
Q4
Sell
-3,994
Closed -$249K 998
2020
Q3
$249K Buy
+3,994
New +$250K ﹤0.01% 814

Other funds holding NHC

Connor, Clark & Lunn Investment Management (CC&L)'s NHC Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its National Healthcare (NHC) stake by 3.2% in Q2 2026, selling an estimated $40.4K and leaving 6,672 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1103.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NHC in Q3 2020 and has held it in 8 quarters since. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 6,672 shares of National Healthcare worth $1.41M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 220 National Healthcare shares in Q2 2026, an estimated $40.4K.
  • National Healthcare made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1103 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in National Healthcare in Q3 2020 and has held it in 8 quarters since.
  • 249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.